Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference
22 mai 2024 16h15 HE
|
Elevai Labs Inc.
Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference
Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
01 mai 2024 09h00 HE
|
Elevai Labs Inc.
Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
MYOS Corporation to Present Mechanism of Action Data at the Experimental Biology Conference
23 févr. 2015 07h30 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Feb 23, 2015) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
MYOS Corporation Reports 2014 Third Quarter Results and Provides Business Update
14 nov. 2014 10h30 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Nov 14, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
MYOS Corporation to Announce Second Quarter 2014 Financial Results on August 14, 2014
07 août 2014 08h05 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Aug 7, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
MYOS Corporation Announces Third Quarter Results;
07 nov. 2013 08h25 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Nov 7, 2013) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of therapeutic and dietary products that...
MYOS to Study Synergistic Effects of Myostatin Inhibition on Testosterone-Mediated Muscle Growth; Brigham and Women's Hospital, a Teaching Affiliate of Harvard Medical School, to Conduct the Study
15 août 2013 08h00 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Aug 15, 2013) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of therapeutic and dietary products that...
UPDATE: MYOS Reports Second Quarter 2013 Financial Results and Recent Key Operational Highlights
13 août 2013 14h16 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Aug 13, 2013) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of therapeutic and dietary products that...
MYOS Reports Second Quarter 2013 Financial Results and Recent Key Operational Highlights
13 août 2013 08h00 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Aug 13, 2013) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of therapeutic and dietary products that...
MYOS Signs Exclusive Supply Contract, Plans New Product R&D, With DIL
11 juil. 2013 08h05 HE
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Jul 11, 2013) - MYOS Corporation (OTCBB: MYOS), a company focused on the discovery, development and commercialization of products that improve human muscle health...